The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Avenue Biosciences technology collects data sets on how specific signal peptides impact specific protein targets.

Novartis has significantly strengthened its neuroscience pipeline over recent years, topped by the $12bn acquisition of ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...

Kinisis Ventures closed the final quarter of 2025 with its Fund I and Fund II portfolios demonstrating significant ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome ...

As we look ahead to the future, there's the expectation there may be breakthroughs in space travel, such as human Mars ...